Effect of Music on the Sedative Use During Coronary Angioplasty

Effect of Music on the Reduction of the Sedative Dose During Coronary Angioplasty: A Control-case Comparison Clinical Study

This is a non-blinded, non-randomized controlled pilot study with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is a non-blinded, non-randomized controlled pilot study with patients who will be followed during their coronary angiography procedure and with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner. It is expected to enroll around 100 patients and this is estimated to be obtained in a period of 2 months approximately. Patients will be placed in the control group, without music intervention, or assigned to the music group. Assignment will be done in this manner due to limited availability of the hardware and software to the investigation team. Patients in both groups will be matched based on age, sex, weight, height, American Society of Anesthesiology (ASA) score, and prior medical history, including diabetes, hypertension, chronic kidney disease and stroke. Each patient will receive a standardized sedation in the traditional manner and at the discretion of the investigator to reach Bispectral index (BIS) score below 90 and sedation score ≤ 1. The primary study end points will be the consumptions in analgesics and hypnotics. Secondary study end points will be pain and anxiety scores as measured the Numeric Rating Scale (NRS), the Visual Analog Scale (VAS) and the Amsterdam Preoperative Anxiety and Information Scale (APAIS).

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Neuilly-sur-Seine, France, 92200
        • American Hospital of Paris

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient needs a coronary angiography
  • Patient gives verbal consent to participation in the study.

Exclusion Criteria:

  • Patient aged less than 18 years at time of enrollment
  • Patient doesn't like music for cultural reason
  • Patient with serious psychiatric disorders
  • Patient with not paired deafness or paired one with devices that are incompatible with wearing a headset.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
The control group will undergo coronary angiography without music intervention.
Experimental: Music therapy
The intervention group will also undergo coronary angiography and will administer music therapy between 10 minutes prior to the beginning of the procedure until its end.
The intervention group will administer "U" sequence between 10 minutes prior to the beginning of the procedure until its end.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dose Use of Midazolam Medication (mg)
Time Frame: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
The consumption in Midazolam medication was reported during the coronary angioplasty. Dose was in mg.
Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Dose Use of Propofol Medication (mg)
Time Frame: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
The consumption in Propofol medication was reported during the coronary angioplasty. Dose was in mg.
Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Dose Use of Sufentanil Medication (ug)
Time Frame: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
The consumption in Sufentanil medication was reported during the coronary angioplasty. Dose was in ug.
Between 10 minutes prior to the beginning of the procedure up to 45 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Score
Time Frame: From 0 up to 45 minutes.
Pain score was measured using the Visual Analog Scale (VAS). This scale ranged from 0 (no pain) to 10 (very high pain), and collected the maximum pain the patient had during the procedure. This was collected right after the end of the procedure in the recovery room.
From 0 up to 45 minutes.
Anxiety Score (NRS)
Time Frame: From 0 up to 45 minutes.
Anxiety score was measured using the Numeric Rating Scale (NRS). This scale ranged from 0 (no anxiety) to 10 (very high anxiety), and collected the maximum anxiety the patient had during the procedure. This was collected right after the end of the procedure in the recovery room.
From 0 up to 45 minutes.
Satisfaction of the Patient
Time Frame: Right after the end of the procedure in the recovery room.
Satisfaction was measured using a scale from 0 to 5, with a higher score for a high satisfaction.
Right after the end of the procedure in the recovery room.
Effect on Physiological Parameters: BIS
Time Frame: 10 minutes prior to the beginning of the procedure

Bispectral index (BIS) score at baseline which corresponds to 10 minutes before the beginning of the procedure.

The BIS monitor provides a single dimensionless number which ranges from 0 (equivalent to EEG silence) to 100. Higher is the score, better it is.

10 minutes prior to the beginning of the procedure
Effect on Physiological Parameters: Heart Rate
Time Frame: 10 minutes prior to the beginning of the procedure.
Heart rate at Baseline which corresponds to 10 minutes before the beginning of the procedure.
10 minutes prior to the beginning of the procedure.
Effect on Physiological Parameters: SpO2%
Time Frame: 10 minutes prior to the beginning of the procedure.
SpO2 at Baseline which corresponds to 10 minutes before the beginning of the procedure..
10 minutes prior to the beginning of the procedure.
Effect on Physiological Parameters: Mean Arterial Blood Pressure
Time Frame: 10 minutes prior to the beginning of the procedure.
Mean arterial blood pressure at Baseline which corresponds to 10 minutes before the beginning of the procedure.
10 minutes prior to the beginning of the procedure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gilles BOCCARA, PhD, Department of Anaesthesia and Intensive Care, American Hospital of Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2019

Primary Completion (Actual)

April 3, 2019

Study Completion (Actual)

April 3, 2019

Study Registration Dates

First Submitted

January 12, 2019

First Submitted That Met QC Criteria

January 24, 2019

First Posted (Actual)

January 25, 2019

Study Record Updates

Last Update Posted (Actual)

October 21, 2019

Last Update Submitted That Met QC Criteria

October 17, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • MusicSeda

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Angioplasty

Clinical Trials on Music therapy

3
Subscribe